Cancers arise when the genetic code of normal cells is altered, causing excessive growth. Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) have discovered ...
Jun 29, 2020
0
228
The coronavirus that causes COVID-19 has demonstrated a stubborn ability to resist most nucleoside antiviral treatments, but a new study led by an Iowa State University scientist could help to overcome the virus's defenses.
Aug 3, 2021
0
920
More effective antiviral treatments could be on the way after research from The University of Texas at Austin sheds new light on the COVID-19 antiviral drug remdesivir, the only treatment of its kind currently approved in ...
Jan 28, 2021
0
171
Scientists using a powerful new technology that sequences RNA in 20,000 individual cell nuclei have uncovered new insights into biological events in heart disease. In animal studies, the researchers identified a broad variety ...
Oct 5, 2018
0
73
The COVID-19 pandemic has driven a massive allocation of resources towards producing solutions, from identifying life-saving medications, tracking how the virus spreads and ultimately to preventing infection with vaccines.
Nov 19, 2020
0
21
Widespread testing for the SARS-CoV-2 virus is important to both slow the virus and gain information about how widespread it is in the U.S. But a second aspect of testing has gotten less attention: accuracy.
May 6, 2020
0
1
COVID-19 has changed the lives of millions and even billions of people around the world. The disease is caused by SARS coronavirus 2 (SARS-CoV-2), an RNA virus, i.e. a virus that uses RNA to store its genetic information. ...
Jul 30, 2020
0
178
SARS-CoV-2, the virus that causes COVID-19, likely does not directly infect the brain but can still inflict significant neurological damage, according to a new study from neuropathologists, neurologists, and neuroradiologists ...
Apr 16, 2021
0
38
A new drug could help lower persistent high blood pressure for up to six months following a single injection, a study suggests. If successful, the drug—zilebesiran—would provide a more convenient method for the management ...
Jul 20, 2023
0
22
The United States recently secured 1.7 million doses of a compound that could help to treat COVID-19 patients. In preliminary studies, Molnupiravir reduced the transmission of the SARS-CoV-2 coronavirus. Researchers at the ...
Aug 16, 2021
0
1070
